[Effect of the enkephalin analog dalargin on the course of severe compression shock].
Zoloev
G K
GK
D000818:Animals; D003444:Crush Syndrome / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D004353:Drug Evaluation, Preclinical; D004743:Enkephalin, Leucine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016308:Enkephalin, Leucine-2-Alanine / Q000031:analogs & derivatives*; D008297:Male; D051379:Mice; D051381:Rats; D012774:Shock, Traumatic / Q000188:drug therapy*; D013565:Sympatholytics / Q000627:therapeutic use*; D013997:Time Factors
D013565:Sympatholytics; D004743:Enkephalin, Leucine; D016308:Enkephalin, Leucine-2-Alanine; C040996:enkephalin-Leu, Ala(2)-Arg(6)-
Vliianie analoga énkefalinov dalargina na techenie tiazhelogo kompressionnogo shoka.